Attentional Mechanisms in SCD
NCT06002477
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Subjective Cognitive Decline
Interventions
DRUG:
Mecamylamine Challenge
OTHER:
Placebo Comparator Challenge
Sponsor
Vanderbilt University Medical Center